Heron Therapeutics, Inc.

Heron Therapeutics, Inc.verified

HRTX

Price:

$0.4001

Market Cap:

$63.19M

Heron Therapeutics, Inc. is a biotechnology firm dedicated to creating innovative therapies for critical patient requirements. The company leverages its proprietary Biochronomer drug delivery platform, an advanced system that enables the controlled release of various short-acting pharmacological agents. This technology ensures therapeutic concentrations are maintained for periods ranging from days to weeks following just a single administration. Among its commercialized products is SUSTOL (granisetron), an extended-release injectable designed to prevent both immediate and delayed nausea and vomiting triggered by moderately emetogenic chemotherapy, or specific anthracycline and cyclophosphami...[Read more]

Industry

Biotechnology

IPO Date

1987-08-26

Stock Exchange

NASDAQ

Ticker

HRTX

The PE Ratio as of June 2026 (TTM) for Heron Therapeutics, Inc. (HRTX) is -2.22

According to Heron Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.22. This represents a change of -85.09% compared to the average of -14.89 of the last 4 quarters.

Heron Therapeutics, Inc. (HRTX) Historical PE Ratio (quarterly & annually)

How has HRTX PE Ratio performed in the past?

The mean historical PE Ratio of Heron Therapeutics, Inc. over the last ten years is -7.19. The current -2.22 PE Ratio has changed 2.99% with respect to the historical average. Over the past ten years (40 quarters), HRTX's PE Ratio was at its highest in in the March 2025 quarter at 32.04. The PE Ratio was at its lowest in in the June 2025 quarter at -33.48.

Quarterly (TTM)
Annual

Average

-7.19

Median

-6.70

Minimum

-17.18

Maximum

-1.50

Heron Therapeutics, Inc. (HRTX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Heron Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 708.64%

Maximum Annual PE Ratio = -1.50

Minimum Annual Increase = -68.30%

Minimum Annual PE Ratio = -17.18

Quarterly (TTM)
Annual
YearPE RatioChange
2025-10.73-37.52%
2024-17.18708.64%
2023-2.1241.88%
2022-1.50-63.25%
2021-4.07-51.81%
2020-8.45-9.94%
2019-9.39-11.59%
2018-10.62114.34%
2017-4.9572.61%
2016-2.87-68.30%

Heron Therapeutics, Inc. (HRTX) Average PE Ratio

How has HRTX PE Ratio performed in the past?

The current PE Ratio of Heron Therapeutics, Inc. (HRTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-10.01

5-year avg

-7.12

10-year avg

-7.19

Heron Therapeutics, Inc. (HRTX) PE Ratio vs. Peers

How is HRTX’s PE Ratio compared to its peers?

Heron Therapeutics, Inc.’s PE Ratio is greater than Neonc Technologies Holdings, Inc. (-2.86), greater than Invivyd, Inc. (-3.07), greater than Protara Therapeutics, Inc. (-2.64), greater than SELLAS Life Sciences Group, Inc. (-45.85), greater than Genfit S.A. (-5.37), greater than MediWound Ltd. (-7.01), less than Protalix BioTherapeutics, Inc. (10.88), less than Coherus Oncology, Inc. (-1.26), greater than OmniAb, Inc. (-5.37), greater than Eupraxia Pharmaceuticals Inc. (-8.13),

Build a custom stock screener for Heron Therapeutics, Inc. (HRTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Heron Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Heron Therapeutics, Inc. (HRTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Heron Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Heron Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Heron Therapeutics, Inc. (HRTX)?

What is the highest PE Ratio for Heron Therapeutics, Inc. (HRTX)?

What is the 3-year average PE Ratio for Heron Therapeutics, Inc. (HRTX)?

What is the 5-year average PE Ratio for Heron Therapeutics, Inc. (HRTX)?

How does the current PE Ratio for Heron Therapeutics, Inc. (HRTX) compare to its historical average?